30 Day Trial

LDR Reports Preliminary 3Q15 Revenue

Share:

LDR reported preliminary 3Q15 revenue of $39.3MM, +14.2% from 3Q14. (U.S. $32.3MM, +15%; ex-U.S. $7.0MM, +11.4%; Exclusive Technologies $36.7MM, +18%: Cervical $27.5MM, +25.2%; Lumbar $9.2MM, +0.5%) All growth reflects constant currency.

Cervical product revenue continues to garner principal support from sales of the Mobi-C® Disc. Company leadership notes that seasonality was more pronounced in 3Q15 vs. the prior year. 

Should preliminary numbers hold, in addition to 1H15 revenue, LDR will post YTD15 revenue of $119.8MM, +17.7% vs. 9 mos. 2014 on an as-reported basis.

Source: LDR Holding Corporation